HARDY REGINALD L 4
4 · Brickell Biotech, Inc. · Filed Jan 5, 2021
Insider Transaction Report
Form 4
HARDY REGINALD L
DirectorChairman of the Board
Transactions
- Tax Payment
Common Stock
2020-12-31$0.78/sh−4,873$3,801→ 200,976 total - Award
Common Stock
2021-01-01$0.78/sh+47,435$36,999→ 248,411 total
Holdings
- 21,826(indirect: By Spouse)
Common Stock
- 17,260(indirect: By Trust)
Common Stock
- 266,447(indirect: By Self as General Partner)
Common Stock
- 9,261(indirect: By Spouse)
Common Stock
- 17,260(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs.
- [F2]On January 1, 2021, the reporting person was granted 47,435 RSUs in lieu of a portion of cash compensation as a director of Brickell Biotech, Inc. The RSUs are scheduled to vest on December 31, 2021 and will be settled in the form of one share of common stock for each RSU.